| Literature DB >> 26641132 |
Derek C Medellin1, Qiong Zhou2, Robert Scott1, R Matthew Hill1, Sarah K Frail3, Ramesh Dasari1, Steven J Ontiveros4, Stephen C Pelly5, Willem A L van Otterlo5, Tania Betancourt1,6, Charles B Shuster4, Ernest Hamel7, Ruoli Bai7, Daniel V LaBarbera2, Snezna Rogelj3, Liliya V Frolova3, Alexander Kornienko1.
Abstract
Docking studies of tubulin-targeting C2-substituted 7-deazahypoxanthine analogues of marine alkaloid rigidins led to the design and synthesis of compounds containing linear C2-substituents. The C2-alkynyl analogue was found to have double- to single-digit nanomolar antiproliferative IC50 values and showed statistically significant tumor size reduction in a colon cancer mouse model at nontoxic concentrations. These results provide impetus and further guidance for the development of these rigidin analogues as anticancer agents.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26641132 PMCID: PMC4950951 DOI: 10.1021/acs.jmedchem.5b01426
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446